Latest stories on UNCY
Unicycive Therapeutics, Inc. (UNCY) files 8-K
SEC 8-K50 · neutralgeneral
Unicycive Therapeutics shares rise after second-quarter loss beats forecasts
InvestorsHub58 · neutralearnings
Unicycive Therapeutics GAAP EPS of -$0.06 beats by $0.27
Seeking Alpha68 · bullishearnings
Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
Business Insider55 · neutralgeneral
Unicycive Therapeutics: Two CRLs, One Fixable Problem
Seeking Alpha63 · neutralanalyst
Stock Picks From Seeking Alpha's June 2026 New Analysts
Seeking Alpha57 · neutralanalyst
Unicycive Therapeutics Reports Preliminary Q2 2026 Cash Position
TipRanks50 · neutralgeneral
Unicycive Therapeutics, Inc. (UNCY) files 8-K
SEC 8-K50 · neutralgeneral
Unicycive Therapeutics: Second CRL Exposes Execution Risk Behind OLC Story
Seeking Alpha32 · bearishgeneral
UNCY Stock Clocks Worst Day In A Year — Analysts Keep Buy Ratings Despite ‘5-12 Month Delay’ In Drug Approval
Stocktwits News34 · bearishgeneral
Unicycive plummets following second CRL for OLC for hyperphosphatemia
Seeking Alpha28 · bearishproduct/pr
UNCY Stock Crashed 45% Today – Why Did FDA Reject Its Kidney Disease NDA For A Second Time?
Stocktwits News28 · bearishgeneral
Unicycive Shares Plunge After FDA Again Rejects Oxylanthanum Carbonate
Morningstar22 · bearishproduct/pr
FDA Review for Unicycive’s Oxylanthanum Carbonate Focuses on Third-Party Manufacturing—Efficacy and Safety Remain Unchallenged
MarketChameleon56 · neutralproduct/pr
UNCY Stock Rallies 8% As Retail Traders Anticipate FDA Clearance For Lead Drug Candidate
Stocktwits News67 · bullishgeneral
UNCY Stock On Track For Worst Day In About A Year Ahead Of FDA Decision On Lead Drug
Stocktwits News28 · bearishgeneral
Unicycive seeks to distinguish OLC in crowded CKD hyperphosphatemia market
Seeking Alpha63 · neutralproduct/pr
Unicycive Therapeutics, Inc. (UNCY) files 8-K
SEC 8-K50 · neutralgeneral
Unicycive Expands At-The-Market Equity Offering Program
TipRanks24 · bearishgeneral
UNCY: [Form 4] Unicycive Therapeutics, Inc. Insider Trading Activity
StockTitan SEC50 · neutralgeneral